The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Altshuler, L.
* Articles by Post, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Altshuler, L.
* Articles by Post, R.
Related Collections
* Bipolar Disorder
* Antidepressants
Am J Psychiatry 160:1252-1262, July 2003
© 2003 American Psychiatric Association


Article

Impact of Antidepressant Discontinuation After Acute Bipolar Depression Remission on Rates of Depressive Relapse at 1-Year Follow-Up

Lori Altshuler, M.D., Trisha Suppes, M.D., Ph.D., David Black, M.A., Willem A. Nolen, M.D., Ph.D., Paul E. Keck, Jr., M.D., Mark A. Frye, M.D., Susan McElroy, M.D., Ralph Kupka, M.D., Heinz Grunze, M.D., Jörg Walden, M.D., Ph.D., Gabrielle Leverich, M.S.W., L.C.S.W.-C., Kirk Denicoff, M.D., David Luckenbaugh, M.A., and Robert Post, M.D.

OBJECTIVE: While guidelines for treating patients with bipolar depression recommend discontinuing antidepressants within 6 months after remission, few studies have assessed the implications of this strategy on the risk for depressive relapse. This study examined the effect of antidepressant discontinuation or continuation on depressive relapse risk among bipolar subjects successfully treated for an acute depressive episode. METHOD: Eighty-four subjects with bipolar disorder who achieved remission from a depressive episode with the addition of an antidepressant to an ongoing mood stabilizer regimen were followed prospectively for 1 year. The risk of depressive relapse among 43 subjects who stopped antidepressant treatment within 6 months after remission ("discontinuation group") was compared with the risk among 41 subjects who continued taking antidepressants beyond 6 months ("continuation group"). RESULTS: A Cox proportional hazards regression analysis indicated that shorter antidepressant exposure time following successful treatment was associated with a significantly shorter time to depressive relapse. Furthermore, patients who discontinued antidepressant treatment within the first 6 months after remission experienced a significantly shorter period of euthymia before depressive relapse over the length of 1-year follow-up. One year after successful antidepressant response, 70% of the antidepressant discontinuation group experienced a depressive relapse compared with 36% of the continuation group. By the 1-year follow-up evaluation, 15 (18%) of the 84 subjects had experienced a manic relapse; only six of these subjects were taking an antidepressant at the time of manic relapse. CONCLUSIONS: The risk of depressive relapse in patients with bipolar illness was significantly associated with discontinuing antidepressants soon after remission. The risk of manic relapse was not significantly associated with continuing use of antidepressant medication and, overall, was substantially less than the risk of depressive relapse. Maintenance of antidepressant treatment in combination with a mood stabilizer may be warranted in some patients with bipolar disorder.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
D. Smith, S. Ghaemi, and N Craddock
The broad clinical spectrum of bipolar disorder: implications for research and practice
J Psychopharmacol, June 1, 2008; 22(4): 397 - 400.
[PDF]


Home page
J PsychopharmacolHome page
M. Franks, K. Macritchie, T Mahmood, and A. Young
Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study
J Psychopharmacol, June 1, 2008; 22(4): 452 - 456.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
J. F. Goldberg, R. H. Perlis, S. N. Ghaemi, J. R. Calabrese, C. L. Bowden, S. Wisniewski, D. J. Miklowitz, G. S. Sachs, and M. E. Thase
Adjunctive Antidepressant Use and Symptomatic Recovery Among Bipolar Depressed Patients With Concomitant Manic Symptoms: Findings From the STEP-BD
Am J Psychiatry, September 1, 2007; 164(9): 1348 - 1355.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
G. S. Sachs
Bipolar Disorder Clinical Synthesis: Where Does the Evidence Lead?
Focus, January 1, 2007; 5(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
M. Gitlin
Treatment-Resistant Bipolar Disorder
Focus, January 1, 2007; 5(1): 49 - 63.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
G. S. Leverich, L. L. Altshuler, M. A. Frye, T. Suppes, S. L. McElroy, P. E. Keck Jr., R. W. Kupka, K. D. Denicoff, W. A. Nolen, H. Grunze, et al.
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers
Focus, January 1, 2007; 5(1): 98 - 106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. S. El-Mallakh and A. Karippot
Chronic Depression in Bipolar Disorder
Am J Psychiatry, August 1, 2006; 163(8): 1337 - 1341.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. M. Post, L. L. Altshuler, G. S. Leverich, M. A. Frye, W. A. Nolen, R. W. Kupka, T. Suppes, S. McElroy, P. E. Keck, K. D. Denicoff, et al.
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
The British Journal of Psychiatry, August 1, 2006; 189(2): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
S. N. Ghaemi, D. J. Hsu, M. E. Thase, S. R. Wisniewski, A. A. Nierenberg, S. Miyahara, and G. Sachs
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Psychiatr Serv, May 1, 2006; 57(5): 660 - 665.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
D. J. Smith and S. N. Ghaemi
Hypomania in clinical practice
Advan. Psychiatr. Treat., March 1, 2006; 12(2): 110 - 120.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. S. Leverich, L. L. Altshuler, M. A. Frye, T. Suppes, S. L. McElroy, P. E. Keck Jr., R. W. Kupka, K. D. Denicoff, W. A. Nolen, H. Grunze, et al.
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers
Am J Psychiatry, February 1, 2006; 163(2): 232 - 239.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
S. Frangou
Advancing the pharmacological treatment of bipolar depression
Advan. Psychiatr. Treat., January 1, 2005; 11(1): 28 - 37.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. M. Anderson, P. M. Haddad, and I. Chaudhry
Changes in Pharmacological treatment for Bipolar Disorder Over Time in Manchester: A Comparison with Lloyd et al. (2003)
J Psychopharmacol, September 1, 2004; 18(3): 441 - 444.
[PDF]


Home page
Am. J. PsychiatryHome page
F. SOLDANI, S. N. GHAEMI, L. TONDO, H. S. AKISKAL, and F. K. GOODWIN
Relapse After Antidepressant Discontinuation
Am J Psychiatry, July 1, 2004; 161(7): 1312 - 1313.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Does Discontinuing Antidepressants Soon After Remission Hurt Bipolar Patients?
Journal Watch Psychiatry, September 3, 2003; 2003(903): 3 - 3.
[Full Text]


Home page
Psychiatr. NewsHome page
J. Rosack

Psychiatr News, August 1, 2003; 38(15): 26 - 26.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org